Lijun Liu
Qingdao University(CN)Ministry of Education of the People's Republic of China(CN)Harbin Engineering University(CN)Jiamusi University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Chinese PLA General Hospital(CN)Ministry of Education(RO)Affiliated Hospital of Qingdao University(CN)Peking University People's Hospital(CN)Peking University First Hospital(CN)Institute of Hematology & Blood Diseases Hospital(CN)Ministry of Agriculture and Rural Affairs(CN)China Agricultural University(CN)University of South China(CN)Northeastern University(CN)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, SARS-CoV-2 and COVID-19 Research, Hip disorders and treatments, COVID-19 Clinical Research Studies, CRISPR and Genetic Engineering
Most-Cited Works
- → Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy(2004)776 cited
- → The cell cycle in stem cell proliferation, pluripotency and differentiation(2019)422 cited
- → Cyclin C is a haploinsufficient tumour suppressor(2014)163 cited
- → Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy(2014)153 cited
- → G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells(2017)132 cited
- → Effects of SARS‐CoV‐2 mutations on protein structures and intraviral protein–protein interactions(2020)123 cited